Your browser doesn't support javascript.
loading
The 3D-structure, kinetics and dynamics of the E. coli nitroreductase NfsA with NADP+ provide glimpses of its catalytic mechanism.
White, Scott A; Christofferson, Andrew J; Grainger, Alastair I; Day, Martin A; Jarrom, David; Graziano, Antonio E; Searle, Peter F; Hyde, Eva I.
Afiliación
  • White SA; School of Biosciences, University of Birmingham, UK.
  • Christofferson AJ; School of Science, RMIT University, Melbourne, Australia.
  • Grainger AI; School of Biosciences, University of Birmingham, UK.
  • Day MA; School of Biosciences, University of Birmingham, UK.
  • Jarrom D; Institute for Cancer and Genomic Sciences, University of Birmingham, UK.
  • Graziano AE; School of Biosciences, University of Birmingham, UK.
  • Searle PF; School of Biosciences, University of Birmingham, UK.
  • Hyde EI; Institute for Cancer and Genomic Sciences, University of Birmingham, UK.
FEBS Lett ; 596(18): 2425-2440, 2022 09.
Article en En | MEDLINE | ID: mdl-35648111
ABSTRACT
Nitroreductases activate nitroaromatic antibiotics and cancer prodrugs to cytotoxic hydroxylamines and reduce quinones to quinols. Using steady-state and stopped-flow kinetics, we show that the Escherichia coli nitroreductase NfsA is 20-50 fold more active with NADPH than with NADH and that product release may be rate-limiting. The crystal structure of NfsA with NADP+ shows that a mobile loop forms a phosphate-binding pocket. The nicotinamide ring and nicotinamide ribose are mobile, as confirmed in molecular dynamics (MD) simulations. We present a model of NADPH bound to NfsA. Only one NADP+ is seen bound to the NfsA dimers, and MD simulations show that binding of a second NADP(H) cofactor is unfavourable, suggesting that NfsA and other members of this protein superfamily may have a half-of-sites mechanism.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Profármacos / Proteínas de Escherichia coli Idioma: En Revista: FEBS Lett Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Profármacos / Proteínas de Escherichia coli Idioma: En Revista: FEBS Lett Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido